Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Trident Texofab Ltd.
Source DateBoard Meeting DateDetails
11-Aug-2025 13-Aug-2025 Quarterly Results (Revised)
06-Aug-2025 12-Aug-2025 Quarterly Results
21-May-2025 29-May-2025 Audited Results
29-Jan-2025 03-Feb-2025 Quarterly Results
21-Oct-2024 23-Oct-2024 Inter-alia, to transact the following businesses: 1. To increase the Authorized Share Capital of the Company and consequent amendments in Memorandum of Association of the Company; 2. To consider and evaluate the proposal to raise funds, to accelerate business growth and to augment the long-term financial resources of the Company, by way of issue of Warrants/Equity Shares/Convertible Securities through permissible mode, as may be permitted under applicable laws and subject to all necessary approvals, and to appoint requisite intermediaries required for this purpose; 3. to seek members' approval wherever applicable by means of passing the requisite resolution(s) for the above-said board decisions and other matters connected therewith and/or incidental thereto; and 4. Any other business with the permission of the Chair.
08-Oct-2024 12-Oct-2024 Quarterly Results
16-Jul-2024 18-Jul-2024 Quarterly Results (Revised)
15-Jul-2024 17-Jul-2024 Quarterly Results
21-May-2024 25-May-2024 Audited Results (Revised)
13-May-2024 21-May-2024 Audited Results
05-Mar-2024 13-Mar-2024 Independent Director Meeting
06-Feb-2024 14-Feb-2024 Quarterly Results
26-Oct-2023 06-Nov-2023 Quarterly Results
28-Jul-2023 10-Aug-2023 Quarterly Results & Inter alia to consider and approve including: 1. To approve and take on record the un-audited standalone financial results of the Company for the quarter ended June 30, 2023: 2. To Appoint a Secretarial Auditor for the financial year 2023-24. 3. To Appoint an Internal Auditor for the financial year 2023-24. 4. Any other business with the permission of the Chair.
17-Apr-2023 24-Apr-2023 Audited Results
09-Jan-2023 16-Jan-2023 Quarterly Results
04-Oct-2022 11-Oct-2022 Quarterly Results
26-Sep-2022 01-Oct-2022 (Revised) The Meeting of the Board of Directors of the Company shall not be held on 26th September 2022 due to unavoidable reasons and the same has been postponed to Saturday, 01st October 2022 to consider and approve:- 1. To Borrow or raise fund by issue of Unlisted Secured Redeemable Non-Convertible Debentures for value up to Rs. 12,00,00,000/- (Twelve Crore Only) at Face Value of Rs. 1000/- each (One Thousand Only) in terms of Section 42 and 71 of the Companies Act 2013, read with relevant rules and SEBJ Regulations. 2. To Borrow or raise fund by issue of Unlisted Unsecured Compulsorily Convertible Debentures for value up to Rs. 18,00,00,000/-(Eighteen Crore Only) at Face Value of Rs. 1000/- each (One Thousand Only) in terms of Section 42 and 71 of the Companies Act 2013, read with relevant rules and SEBI Regulations
19-Sep-2022 26-Sep-2022 Inter alia, to consider and approve:- 1. To Borrow or raise fund by issue of Unlisted Secured Redeemable Non-Convertible Debentures for value up to Rs. 12,00,00,000/- (Twelve Crore Only) at Face Value of Rs. 1000/- each (One Thousand Only) in terms of Section 42 and 71 of the Companies Act 2013, read with relevant rules and SEBI Regulations. 2. To Borrow or raise fund by issue of Unlisted Unsecured Compulsorily Convertible Debentures for value up to Rs. 18,00,00,000/-(Eighteen Crore Only) at Face Value of Rs. 1000/- each (One Thousand Only) in terms of Section 42 and 71 of the Companies Act 2013, read with relevant rules and SEBI Regulations. 3. Any Other business with the permission of the Chair.
18-Aug-2022 22-Aug-2022 Inter alia, to consider and approve including ; 1. To decide date, place, time of ensuing annual general meeting for the financial year ended on March 31, 2022 and approve notice for the same. 2. To decide closure of registrar of members and share transfer book of purpose of AGM. 3. To appoint scrutinizer for conducting businesses of AGM. 4. To adopt Directors Report for F.Y. 2021-22 5. Any other business with the permission of the Chair.
Page 1 of 3
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.